• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Canada

Welcome to the international HTA database


Showing [3425 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     Health Quality Ontario (HQO) Capsule Endoscopy in the Assessment of Obscure Gastrointestinal Bleeding: OHTAC Recommendation
2015     Health Quality Ontario (HQO) Is Transient Ischemic Attack a Medical Emergency? OHTAC Recommendation
2015     Health Quality Ontario (HQO) Magnetic Resonance–Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: OHTAC Recommendation
2015     Health Quality Ontario (HQO) Pulmonary Rehabilitation in Ontario: OHTAC Recommendation
2015     Health Quality Ontario (HQO) Caesarean Delivery Rate Review: OHTAC Recommendation
2015     Health Quality Ontario (HQO) Caesarean Delivery Rate Review: An Evidence-Based Analysis
2015     Health Quality Ontario (HQO) Pulmonary Rehabilitation in Ontario: A Cross-Sectional Survey
2015     Health Quality Ontario (HQO) Effect of Increased Intensity of Physiotherapy on Patient Outcomes After Stroke: An Economic Literature Review and Cost-Effectiveness Analysis
2015     Health Quality Ontario (HQO) Effect of Increased Intensity of Physiotherapy on Patient Outcomes After Stroke: An Evidence-Based Analysis
2015     Health Quality Ontario (HQO) Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis
2015     Health Quality Ontario (HQO) Magnetic Resonance–Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis
2015     Health Quality Ontario (HQO) Is Transient Ischemic Attack a Medical Emergency? An Evidence-Based Analysis
2015     Health Quality Ontario (HQO) Capsule Endoscopy in the Assessment of Obscure Gastrointestinal Bleeding: An Economic Analysis
2015     Health Quality Ontario (HQO) Capsule endoscopy in the assessment of obscure gastrointestinal bleeding: an evidence-based analysis
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Development framework for social services practice guidelines]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Assisted reproduction]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Efficacy of intraoperative radiation therapy]
2015     Technology Assessment at SickKids (TASK) A cost-effectiveness analysis of maternal genotyping to guide treatment for postpartum pain and avert infant adverse events
2014     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Evaluation of measures related to the prevention of multiple falls in hospitalized elderly people]
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for constipation: a review of systematic reviews
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment strategies for patients with renal colic: a review of the comparative clinical and cost-effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with cognitive impairment associated with dementia: diagnostic accuracy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Implementation of extracorporeal membrane oxygenation: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Transmission of infectious agents from magazines, books, and toys in healthcare settings: clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting beta2-agonists for chronic obstructive pulmonary disease: safety and harms
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Mass thermography screening for infection and prevention: a review of the clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-contact thermometers for detecting fever: a review of clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Antibacterial sutures for wound closure after surgery: a review of clinical and cost-effectiveness and guidelines for use
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ferumoxytol versus other intravenous iron therapies for anemia: a review of the clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Corneal cross-linking with riboflavin for keratoconus: update of clinical and cost-effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) NxStage home hemodialysis use in remote or rural settings with well water: clinical effectiveness, cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Transmission of infectious agents and risk of injury from patient transfer boards in healthcare settings: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing in the general population: clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ombitasvir/paritaprevir/ritonavir and dasabuvir
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) SYMBIS for neurosurgery and spine application: clinical and cost-effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Foley catheter removal following hip surgery in elderly patients: benefits, harms, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Outpatient self-dialysis programs for patients with chronic renal conditions: clinical and cost-effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sofosbuvir for the treatment of patients with genotype 4 hepatitis C: a review of the clinical efficacy, cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for hepatitis C in previous non-responders: a review of the clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Immediate initiation of continuous positive airway pressure compared with delayed initiation: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Retinal surgeries in non-hospital facilities: clinical and cost-effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Urine testing in long-term care: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Azelastine - HCl and fluticasone propionate
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Islet cell transplantation in patients with unstable diabetes: a review of clinical- and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Post-operative cerebrospinal fluid removal: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal membrane oxygenation for cardiac failure: a review of the clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal membrane oxygenation for acute respiratory failure: a review of the clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Autologous blood reinfusion system for orthopedic surgery: clinical and cost-effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Dexmedetomidine for sedation in the ICU or PICU: a review of cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Linaclotide
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal screening for antibiotic-resistant organisms in long-term care facilities: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Parent advisors in pediatric rehabilitation: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Continuous positive airway pressure compared with oral devices or lifestyle changes for the treatment of obstructive sleep apnea: a review of the clinical and cost-effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Urine testing in long-term care: clinical and cost effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous administration of medications in home care settings: clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Frequency of rescreening of patients negative for antibiotic resistant organisms: clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium bromide
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tramadol for the management of pain in adult patients: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable ultrasound devices for obstetrical or prenatal assessment in rural or remote settings: a review of the diagnostic accuracy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Psychiatrist-led care of patients with dementia and psychiatric disorders in long-term care settings: clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with cognitive impairment associated with a cerebrovascular accident or traumatic brain injury: diagnostic accuracy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography imaging for the diagnosis of renal colic: a review of clinical and cost-effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and risk stratification for diabetic foot ulcers: a review of clinical effectiveness, cost-effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcranial magnetic stimulation for the treatment of adults with PTSD, GAD, or depression: a review of clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Locked units to limit access for dementia patients in long-term care facilities: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Neuro-linguistic programming for the treatment of adults with post-traumatic stress disorder, general anxiety disorder, or depression: a review of clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aripiprazole for pregnant women: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Brain electrical activity mapping for diagnosing psychiatric disorders: a review of the clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Prolotherapy for the management of musculoskeletal pain: a review of the clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Slow-release opioids for postoperative pain: clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Developmental effects of in utero exposure to prescription drug abuse in infants and young children: harms
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Naloxone prescribing: guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with cognitive impairment associated with a neurological impairment: diagnostic accuracy
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term sustained clinical remission after stopping first-line anti-TNF agents in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis: clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic and non-pharmacologic treatments for alcohol withdrawal in the outpatient setting: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014     Institute of Health Economics (IHE) Hysteroscopic tubal sterilization
2014     Institute of Health Economics (IHE) Endovenous ablation interventions for symptomatic varicose veins of the legs
2014     Institute of Health Economics (IHE) First and second trimester prenatal screening update
2014     Institute of Health Economics (IHE) Low dose computed tomography for the screening of lung cancer in adults
2014     HTA Unit, University of Calgary Best practices in the management of behavioural and psychological symptoms of dementia in residents of long-term care facilities in Alberta
2014     HTA Unit, University of Calgary Repetitive transcranial magnetic stimulation for treatment resistant depression
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of chlorhexidine gluconate with alcohol for the prevention of peripheral intravenous device infections: a review of clinical and cost effectiveness, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Positive expiratory pressure devices and incentive spirometers for the prevention of pneumonia: comparative clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Hearing protection fit testing systems: clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Antiemetics for adults experiencing opioid-induced nausea: a review of clinical and cost-effectiveness, benefits and harms, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Junctional tourniquets for controlling hemorrhage from wounds in adults: a review of clinical effectiveness, cost-effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal oxygen saturation range for adults suffering from traumatic brain injury: a review of patient benefit, harms, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Anesthetic injections into the stellate ganglion for the treatment of hot flashes in women: a review of clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Suspended ceiling lifts: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) BMI reduction and chronic disease management: clinical evidence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Aspirating versus not aspirating prior to injection of medication: comparative clinical evidence and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term use of ondansetron, dolasetron and granisetron for the prevention of nausea and vomiting: a review of the clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines